Company Filing History:
9 out of 297 
1 out of 29 
1 out of 2,009 
Years Active: 1991-2015
Title: Innovations and Contributions of Jordan U Gutterman
Introduction
Jordan U Gutterman is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds and methods for treating various diseases. With a total of 13 patents to his name, Gutterman's work has the potential to impact the medical community significantly.
Latest Patents
Among his latest patents is a groundbreaking work on derivatives of avicin D. This patent discloses novel oxetane derivatives of avicin D, including compounds that have specific formulas defined within the patent. The invention also includes pharmaceutical compositions, kits, and articles of manufacture that comprise these derivative compounds. Furthermore, methods and intermediates useful for making these derivatives are provided, along with applications for treating cancer. Another significant patent focuses on compositions for the reversible thioesterification of signaling proteins. This method utilizes avicins and other thioesterification agents to modify cysteine groups of signaling proteins, thereby altering their activity. The pathologies associated with these proteins, including atherosclerosis, cancer, bacterial infections, inflammation, and neurological disorders, can be treated using these innovative thioesterification agents.
Career Highlights
Jordan U Gutterman has worked with the Research Development Foundation, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and application of pharmaceutical compounds.
Collaborations
Throughout his career, Gutterman has collaborated with notable individuals such as Charles Joel Arntzen and Mary E Blake. These collaborations have further enriched his research and development efforts.
Conclusion
Jordan U Gutterman's innovative work in the field of pharmaceuticals showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to addressing significant health challenges through innovative solutions.